UK markets closed
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • FTSE 250

    19,835.95
    +146.93 (+0.75%)
     
  • AIM

    956.64
    +9.47 (+1.00%)
     
  • GBP/EUR

    1.1822
    +0.0040 (+0.34%)
     
  • GBP/USD

    1.2495
    +0.0020 (+0.16%)
     
  • BTC-GBP

    23,611.57
    +210.19 (+0.90%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • CRUDE OIL

    110.35
    +0.46 (+0.42%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • CAC 40

    6,285.24
    +12.53 (+0.20%)
     

In Vitro Diagnostics Business Outlook 2022: Twice-Monthly Publication Dedicated to IVD

·1-min read
Company Logo
Company Logo

Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics Business Outlook" newsletter has been added to ResearchAndMarkets.com's offering.

The twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook will offer the following:

  • Market Sizing and Forecasting of IVD Market Segments in Every Issue

  • Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care-Updates on the Important Test Categories You Need to Know About

  • Industry Watch - Developments with COVID-19 and Other Testing

  • M&A, Distribution, Partnerships Tracked and Charted

  • New Product Introductions and Company Announcements

  • Company Profiling and Quarterly Results Summaries

  • Regional Market Coverage

For more information about this newsletter visit https://www.researchandmarkets.com/r/39it8x

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting